Modified RTK-GNSS for Challenging Environments.

Real-Time Kinematic Global Navigation Satellite System (RTK-GNSS) is currently the premier technique for achieving centimeter-level accuracy quickly and easily. However, the robustness of RTK-GNSS diminishes in challenging environments due to severe multipath effects and a limited number of available GNSS signals. This is a pressing issue, especially for GNSS users in the navigation industry.

Proposed Orbital Products for Positioning Using Mega-Constellation LEO Satellites.

With thousands of low Earth orbit (LEO) satellites to be launched in the near future, LEO mega-constellations are supposed to significantly change the positioning and navigation service for ground users. The goal of this contribution is to suggest and discuss the feasibility of possible procedures to generate the LEO orbital products at two accuracy levels to facilitate different positioning methods-i.e.

Mortality and Morbidity in Office-Based General Anesthesia for Dentistry in Ontario.

Our objective was to estimate the prevalence of mortality and serious morbidity for office-based deep sedation and general anesthesia (DS/GA) for dentistry in Ontario from 1996 to 2015. Data were collected retrospectively in 2 phases. Phase I involved the review of incidents, and phase II involved a survey of DS/GA providers.

A GPS Spoofing Generator Using an Open Sourced Vector Tracking-Based Receiver.

Spoofing can seriously threaten the use of the Global Positioning System (GPS) in critical applications such as positioning and navigation of autonomous vehicles. Research into spoofing generation will contribute to assessment of the threat of possible spoofing attacks and help in the development of anti-spoofing methods. However, the recent commercial off-the-shelf (COTS) spoofing generators are expensive and the technology implementation is complicated.

Novel molecular triggers underlie valproate-induced liver injury and its alleviation by the omega-3 fatty acid DHA: role of inflammation and apoptosis.

Background/aim: Hepatic injury is a hallmark adverse reaction to Valproate (VPA), a common used drug in the management of numerous CNS disorders, including epilepsy. DHA has a myriad of health benefits, including renal- and hepato-protective effects. Unfortunately, however, the underpinnings of such liver-pertinent VPA- and DHA-actions remain largely undefined.